CN1929843A - 治疗高血脂症的组合物 - Google Patents

治疗高血脂症的组合物 Download PDF

Info

Publication number
CN1929843A
CN1929843A CN200580007179.2A CN200580007179A CN1929843A CN 1929843 A CN1929843 A CN 1929843A CN 200580007179 A CN200580007179 A CN 200580007179A CN 1929843 A CN1929843 A CN 1929843A
Authority
CN
China
Prior art keywords
acipimox
pitavastatin
pitavastatin calcium
composition
groups
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN200580007179.2A
Other languages
English (en)
Inventor
赵志全
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Lunan Pharmaceutical Group Corp
Original Assignee
Lunan Pharmaceutical Group Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunan Pharmaceutical Group Corp filed Critical Lunan Pharmaceutical Group Corp
Priority to CN200580007179.2A priority Critical patent/CN1929843A/zh
Priority claimed from PCT/CN2005/000728 external-priority patent/WO2005115393A1/zh
Publication of CN1929843A publication Critical patent/CN1929843A/zh
Pending legal-status Critical Current

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

本发明提供一种新的治疗高脂血症的药物组合物，其包括的第一个活性成分为阿昔莫司，第二个活性成分匹伐他汀、或其可药用的盐、酯或溶剂化物；第一与第二活性成分(以游离酸计)的重量比为(50－800)∶1，优选重量比为(100－400)∶1，进一步优选重量比为200∶1。阿昔莫司和匹伐他汀的联合应用，其降脂作用明显优于相同剂量的单方，表明两药合用有协同作用，同时又无明显的毒性作用，且与阿昔莫司普伐他汀联合使用、阿昔莫司洛伐他汀联合使用相比较，降脂效果更为明显。

Description

PCT国内申请，说明书已公开。

Claims (1)

  1. PCT国内申请，权利要求书已公开。
CN200580007179.2A 2004-05-25 2005-05-25 治疗高血脂症的组合物 Pending CN1929843A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN200580007179.2A CN1929843A (zh) 2004-05-25 2005-05-25 治疗高血脂症的组合物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CN200410024204 2004-05-25
CN200410024204.5 2004-05-25
PCT/CN2005/000728 WO2005115393A1 (fr) 2004-05-25 2005-05-25 Composition anti-hyperlipemie
CN200580007179.2A CN1929843A (zh) 2004-05-25 2005-05-25 治疗高血脂症的组合物

Related Child Applications (1)

Application Number Title Priority Date Filing Date
CNB2008101104318A Division CN100566717C (zh) 2005-05-25 2005-05-25 治疗高血脂症的组合物

Publications (1)

Publication Number Publication Date
CN1929843A true CN1929843A (zh) 2007-03-14

Family

ID=37859470

Family Applications (1)

Application Number Title Priority Date Filing Date
CN200580007179.2A Pending CN1929843A (zh) 2004-05-25 2005-05-25 治疗高血脂症的组合物

Country Status (1)

Country Link
CN (1) CN1929843A (zh)

Similar Documents

Publication Publication Date Title
RU2298418C2 (ru) Комбинация по меньшей мере двух соединений, выбранных из групп антагонистов at1-рецептора или ингибиторов асе (ангиотензинпревращающий фермент), или ингибиторов hmg-coa-редуктазы (бета-гидрокси-бета-метилглутарил-кофермент-а-редуктаза)
US20060029668A1 (en) Sustained release L-arginine formulations and methods of manufacture and use
AU2003284962B2 (en) Sustained release L-arginine formulations and methods of manufacture and use
CA3012675C (en) A pharmaceutical composition for prevention of diet induced obesity
AU2004279298B2 (en) Sustained release L-arginine formulations and methods of manufacture and use
CA2555316A1 (en) Combined pharmaceutical composition
KR20010093845A (ko) 피브레이트와 세리바스타틴의 복합제제
CN103239725A (zh) 一种治疗心脑血管疾病复方制剂
CN1925857A (zh) 治疗高血脂症的组合物
WO2005123082A1 (fr) Composition anti-hyperlipemie
CN110063944A (zh) 一种苯磺酸左旋氨氯地平阿托伐他汀钙片及其制备方法
US20080145424A1 (en) Sustained release L-arginine formulations and methods of manufacture and use
CN100566716C (zh) 治疗高血脂症的组合物
CN1929843A (zh) 治疗高血脂症的组合物
CN100358526C (zh) 治疗高血脂症的组合物
CN100566717C (zh) 治疗高血脂症的组合物
CN1925858A (zh) 治疗高血脂症的组合物
CN113134086B (zh) 一种降血脂的药物组合物
CN101357132B (zh) 治疗高血脂症的组合物
WO2005115393A1 (fr) Composition anti-hyperlipemie
CN1332657C (zh) 一种含洛伐他汀的组合物及其用途
MXPA01006136A (en) Combination of cerivastatin and fibrates
CN1701794A (zh) 治疗高血脂症的组合物

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication
REG Reference to a national code

Ref country code: HK

Ref legal event code: WD

Ref document number: 1093908

Country of ref document: HK